40% Weight Reduction - ATOUN to Launch New Power Assist Suits for the Hip, Suitable for Caregiving
In April 2018, ATOUN Inc. (headquarters in Nara City, Nara Prefecture, President: Hiromichi Fujimoto, hereafter referred to as "ATOUN") will begin selling the all new Power Assist Suit for the hip (*1) "ATOUN MODEL Y," which is 40% lighter in weight (*2) than the current model (*3).
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171226005239/en/
New Power Assist Suit for the hip "ATOUN MODEL Y" (Photo: Business Wire)
ATOUN developed the new "ATOUN MODEL Y" by reexamining the design and control from scratch based on user feedback of the current model, and also successfully reduced weight by 40% by replacing the metal frame with one made of resin, and making the motors and batteries more compact. At the same time, the development team also made efforts to commoditize components used and simplify the assembly process to significantly curtail costs, thereby making the power assist suit more affordable and accessible.
The current model is being used at construction sites, logistic centers, factories, and farms, and based on the know-how gained in these fields, ATOUN has made numerous improvements in accuracy and durability. As a result, the new "ATOUN MODEL Y" boasts a better fit, smoother movement, and higher mobility. And to put these new features to good use, ATOUN will propose the application of this suit in caregiving.
Before this product is introduced to the Japanese market, the new "ATOUN MODEL Y" will be introduced on a trial basis overseas. A memorandum of understanding has already been signed with a major construction company in Hong Kong, Gammon Construction Limited, and the company will be conducting trials with 10 suits beginning in February 2018.
According to CEO Thomas Ho of Gammon Construction Limited: "By using the exoskeleton technology, we aim at improving construction health and safety as well as working conditions and competence."
Pre-orders for the ATOUN MODEL Y began on December 21, 2017.
*1: Power Assist Suits for the hip
An assistance robot designed to be worn by the user. Location sensors detect the body's core movement and the motors on the hip turn in synch with the intended movement to reduce the burden on the hip.
*2: 40% weight reduction
"ATOUN MODEL A" (current model) weighs 7.4kg in total, while the new "ATOUN MODEL Y" only weighs 4.4kg in total, equivalent to 40.54% in weight reduction.
*3: Current model
Power Assist Suit for the hip, the "ATOUN MODEL A." Introduced to the market in fall 2015.
ATOUN Inc. Sales managers: Miwa, Sonoda
Contact page: http://atoun.co.jp/contact
Established by using in-house venture system of Panasonic in 2003. ATOUN creates a new value and possibility to all workers by providing power assist products such as wearable robot "Power Assist Suit". ATOUN aims to achieve "Power-Barrierless Society" where the people can work regardless of their age and gender.
[Video] Creating a future together with our customers - The development of Activelink's Power Assist Suit
Panasonic's Power Assist Suit Enters Joint Development of Construction Technology in Hong Kong (Nov 29, 2017)
Power Assist Suit Demonstration Experiment at the 2017 Para Powerlifting Japan Cup - Helped Lighten the Load for Staff Handling Plates (Jul 28, 2017)
Creating a Future Together with Our Customers - The Development of Activelink's Power Assist Suit (May 25, 2016)
No More Power Barriers with Panasonic Assist Robots (Mar 23, 2016)
Panasonic Introduces People-Centric Robotics Technology at International Robot Exhibition 2017 (Nov 29, 2017)
Gammon Construction Limited
Global Communications Department
Global PR Office
Click here to go to Media Contact form
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Manchester United and True Religion Launch Denim Range19.10.2018 17:37 | Pressemelding
Manchester United (NYSE:MANU) and luxury denim brand True Religion have collaborated to launch a range of premium club branded denim wear. A first for the club, the new global partnership with the iconic American denim brand will see a range of men’s & women’s co-branded styles go on sale beginning 26th October in the club’s Megastore as well as online via United Direct and truereligion.com & eu.truereligion.com. The exclusive collection features jeans, shirts and jackets, including a highly desirable limited edition denim jacket embroidered with the club’s crest. Fans will have the opportunity to win a selection of clothing from the new range by visiting www.manutd.com/truereligion. Manchester United’s Group Managing Director, Richard Arnold, comments: “True Religion is a well-known, established name in fashion, creating unique designs without compromising on quality. The range we have collaborated on includes the same attention to detail and craftsmanship that has made True Religion
Arch Insurance Announces Strategic Leadership Changes19.10.2018 13:10 | Pressemelding
Arch Insurance today announced that Matt Shulman will assume the newly created role of CEO, Arch Insurance North America, effective January 1, 2019. In this role, he will lead Arch Insurance’s operations in the United States and Canada. He will report to Nicolas Papadopoulo, Chairman and CEO of Arch Worldwide Insurance Group. Mr. Shulman, who has more than 20 years of experience in the insurance industry, has been with Arch Insurance since 2009 and has served as the President and CEO of Arch Insurance Europe since 2016. “Matt brings significant U.S. and international experience to this role. Under his leadership, together with our senior team, Arch Insurance will continue to enhance our value proposition to our customers through a robust, diversified product portfolio, creative solutions and excellent service,” Mr. Papadopoulo said. Arch Insurance has also created a new organizational structure with three Chief Underwriting Officers (CUO) dedicated to specific lines of business. These
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer19.10.2018 12:00 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1 st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients. Data for these secondary endpoints will be presented in a poster discussion at the European Society for Medical Oncology (ESMO) 2018 Congress on Friday, October 19 at 2:00 p.m. CET in Munich, Germany. These results further support ALUNBRIG as a potential treatment for adults with ALK+ locally advanced or metastatic NSCLC who had not received a prior ALK inhibitor. ALUNBRIG is currently not approved as first-line therapy for advanced ALK+ NSCLC. “ALK+ NSCLC often spreads to the brain, so having options that can clearly demonstrate efficacy both in the brain an
Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Patients With Cystic Fibrosis Aged 12 to <24 months With Certain Mutations in the CFTR Gene19.10.2018 11:54 | Pressemelding
Vertex Pharmaceuticals (Europe) Limited today announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for KALYDECO® (ivacaftor) to include the treatment of people with cystic fibrosis (CF) aged 12 to <24 months who have at least one of the following nine mutations in their cystic fibrosis transmembrane conductance regulator (CFTR) gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF in patients aged 12 to <24 months, who have specific mutations in the CFTR gene. “Cystic fibrosis is a chronic, progressive disease that is present at birth, with symptoms often occurring in infancy, so early treatment is crucial to deliver the best possible outcomes for patients,” said Reshma Kewalr
Schlumberger Announces Third-Quarter 2018 Results19.10.2018 11:00 | Pressemelding
Schlumberger Limited (NYSE: SLB) today reported results for the third quarter of 2018. (Stated in millions, except per share amounts) Three Months Ended Change Sept. 30, 2018 Jun. 30, 2018 Sept. 30, 2017 Sequential Year-on-year Revenue $8,504 $8,303 $7,905 2% 8% Pretax operating income $1,152 $1,094 $1,059 5% 9% Pretax operating margin 13.5% 13.2% 13.4% 36 bps 15 bps Net income - GAAP basis $644 $430 $545 50% 18% Net income, excluding charges & credits* $644 $594 $581 8% 11% Diluted EPS - GAAP basis $0.46 $0.31 $0.39 48% 18% Diluted EPS, excluding charges & credits* $0.46 $0.43 $0.42 7% 10% North America revenue $3,189 $3,139 $2,602 2% 23% International revenue $5,215 $5,065 $5,147 3% 1% North America revenue, excluding Cameron $2,572 $2,546 $2,086 1% 23% International revenue, excluding Cameron $4,559 $4,387 $4,430 4% 3% *These are non-GAAP financial measures. See section below entitled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commented, “Our third
Tradeshift Announces Q3 2018 Results19.10.2018 11:00 | Pressemelding
Tradeshift, the leader in supply chain payments and marketplaces, today announced results from the third quarter of 2018, marking the tenth quarter in a row of successive growth and beating targets. Tradeshift’s third quarter growth stats announced today include: YoY revenue grew 400 percent (trailing 12 months) YoY new bookings grew 284 percent YoY gross merchandise volume (GMV) grew 262 percent New total contract value grew by $47M in Q3 Tradeshift’s customer roster continued strong growth this quarter adding 27 new customers, including Hertz, Shiseido, ECU, and Fortune 500 leaders in retail apparel, agriculture, engineering and construction, hospitality, travel and food delivery. Tradeshift also expanded its app ecosystem by adding a key partnership with Coface, a global credit insurer. Coface has announced a new app solution on the Tradeshift platform offering risk and business information services to help businesses make decisions by ensuring greater financial transparency between